Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 7;29(1):137.
doi: 10.1186/s11658-024-00658-7.

Human Gb3/CD77 synthase: a glycosyltransferase at the crossroads of immunohematology, toxicology, and cancer research

Affiliations
Review

Human Gb3/CD77 synthase: a glycosyltransferase at the crossroads of immunohematology, toxicology, and cancer research

Katarzyna Szymczak-Kulus et al. Cell Mol Biol Lett. .

Abstract

Human Gb3/CD77 synthase (α1,4-galactosyltransferase, P1/Pk synthase, UDP-galactose: β-D-galactosyl-β1-R 4-α-D-galactosyltransferase, EC 2.4.1.228) forms Galα1 → 4Gal structures on glycosphingolipids and glycoproteins. These glycans are recognized by bacterial adhesins and toxins. Globotriaosylceramide (Gb3), the major product of Gb3/CD77 synthase, is a glycosphingolipid located predominantly in plasma membrane lipid rafts, where it serves as a main receptor for Shiga toxins released by enterohemorrhagic Escherichia coli and Shigella dysenteriae of serotype 1. On the other hand, accumulation of glycans formed by Gb3/CD77 synthase contributes to the symptoms of Anderson-Fabry disease caused by α-galactosidase A deficiency. Moreover, variation in Gb3/CD77 synthase expression and activity underlies the P1PK histo-blood group system. Glycosphingolipids synthesized by the enzyme are overproduced in colorectal, gastric, pancreatic, and ovarian cancer, and elevated Gb3 biosynthesis is associated with cancer cell chemo- and radioresistance. Furthermore, Gb3/CD77 synthase acts as a key glycosyltransferase modulating ovarian cancer cell plasticity. Here, we describe the role of human Gb3/CD77 synthase and its products in the P1PK histo-blood group system, Anderson-Fabry disease, and bacterial infections. Additionally, we provide an overview of emerging evidence that Gb3/CD77 synthase and its glycosphingolipid products are involved in cancer metastasis and chemoresistance.

Keywords: Anderson-Fabry disease; Shiga toxin; blood group; cancer; chemoresistance; glycoprotein; glycosphingolipid; glycosyltransferase.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Structure of Gb3/CD77 synthase. A The 3D structure model predicted by AlphaFold (https://alphafold.ebi.ac.uk/entry/Q9NPC4); amino acid residues 1–22 compose the cytoplasmic tail, 23–43 form the transmembrane domain, and 44–353 encompass the stem and catalytic domain facing Golgi lumen. B A schematic representation of the Gb3/CD77 synthase polypeptide chain with important peptide motifs highlighted
Fig. 2
Fig. 2
A schematic representation of the biosynthesis of GSLs and N-glycans produced by Gb3/CD77 synthase. Galα1 → 4Gal structures are highlighted in green, and Galα1 → 4GalNAc in red. Color coding according to the Symbol Nomenclature for Glycans (SNFG) [120]
Fig. 3
Fig. 3
Schematic representation of the A4GALT gene. The rectangles depict the three exons. The circles indicate the positions of SNPs associated with P1/P2 polymorphism (rs5751348 in red, rs2143918 and rs8138197 in blue), and the yellow circle represents the rs397514502 SNP resulting in p.Q211E substitution

References

    1. Albesa-Jové D, Guerin ME. The conformational plasticity of glycosyltransferases. Curr Opin Struct Biol. 2016;40:23–32. 10.1016/j.sbi.2016.07.007. - PubMed
    1. Jacob F, Alam S, Konantz M, Liang C, Kohler RS, Everest-Dass AV, et al. Transition of mesenchymal and epithelial cancer cells depends on α1-4 galactosyltransferase-mediated glycosphingolipids. Cancer Res. 2018;78:2952–65. 10.1158/0008-5472.CAN-17-2223. - PubMed
    1. Mikolajczyk K, Bereznicka A, Szymczak-Kulus K, Haczkiewicz-Lesniak K, Szulc B, Olczak M, et al. Missing the sweet spot: one of the two N-glycans on human Gb3/CD77 synthase is expendable. Glycobiology. 2021;31:1145–62. 10.1093/glycob/cwab041. - PubMed
    1. Mikolajczyk K, Sikora M, Hanus C, Kaczmarek R, Czerwinski M. One of the two N-glycans on the human Gb3/CD77 synthase is essential for its activity and allosterically regulates its function. Biochem Biophys Res Commun. 2022;617:36–41. 10.1016/j.bbrc.2022.05.085. - PubMed
    1. Yamaji T, Sekizuka T, Tachida Y, Sakuma C, Morimoto K, Kuroda M, et al. A CRISPR screen identifies LAPTM4A and TM9SF proteins as glycolipid-regulating factors. IScience. 2019;11:409–24. 10.1016/j.isci.2018.12.039. - PMC - PubMed

Substances